2月25日，楚天科技涨2.55%，成交额2.80亿元。两融数据显示，当日楚天科技获融资买入额2773.87万 元，融资偿还1328.99万元，融资净买入1444.88万元。截至2月25日，楚天科技融资融券余额合计2.51亿 元。 截至9月30日，楚天科技股东户数2.89万，较上期增加4.10%；人均流通股19913股，较上期减少3.94%。 2025年1月-9月，楚天科技实现营业收入38.96亿元，同比减少6.60%；归母净利润8446.35万元，同比增 长145.11%。 分红方面，楚天科技A股上市后累计派现3.61亿元。近三年，累计派现1.17亿元。 机构持仓方面，截止2025年9月30日，楚天科技十大流通股东中，香港中央结算有限公司位居第三大流 通股东，持股938.65万股，相比上期减少80.06万股。安信医药健康股票A（010709）位居第八大流通股 东，持股173.38万股，为新进股东。国寿安保智慧生活股票A（001672）退出十大流通股东之列。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公 ...

Group 1 - Chutian Technology's stock increased by 5.22% to 11.90 CNY per share, with a trading volume of 379 million CNY and a turnover rate of 4.63%, resulting in a total market capitalization of 8.51 billion CNY [1] - The company, established on November 8, 2002, and listed on January 21, 2014, is based in Changsha, Hunan Province, and specializes in pharmaceutical equipment and comprehensive technical solutions [1] - The revenue composition of Chutian Technology includes: testing and packaging solutions (24.88%), parts and after-sales service (16.44%), biological engineering solutions (14.84%), sterile preparation solutions (14.61%), pharmaceutical water equipment and engineering system integration (13.81%), solid preparation solutions (10.85%), EPC engineering design services (3.57%), and other products (1.01%) [1] Group 2 - Anxin Fund's Anxin Medical Health Stock A (010709) entered the top ten circulating shareholders of Chutian Technology, holding 1.7338 million shares, which is 0.3% of the circulating shares, with an estimated floating profit of approximately 1.0229 million CNY [2] - Anxin Medical Health Stock A was established on January 12, 2021, with a current scale of 413 million CNY, and has achieved a year-to-date return of 12.99%, ranking 365 out of 5520 in its category, and a one-year return of 78.51%, ranking 314 out of 4203 [2]

Group 1 - The core viewpoint of the news is that Chutian Technology has shown significant stock price growth and positive financial performance indicators in recent months [1][2]. - As of January 13, Chutian Technology's stock price increased by 17.57% year-to-date, with a 10.57% rise over the last five trading days and a 27.04% increase over the last 20 days [1]. - The company reported a revenue of 3.896 billion yuan for the period from January to September 2025, which represents a year-on-year decrease of 6.60%, while the net profit attributable to shareholders increased by 145.11% to 84.4635 million yuan [2]. Group 2 - Chutian Technology's main business involves pharmaceutical equipment and comprehensive technical solutions, with revenue composition including packaging solutions (24.88%), parts and after-sales services (16.44%), and various engineering solutions [1]. - The company has distributed a total of 361 million yuan in dividends since its A-share listing, with 117 million yuan distributed in the last three years [3]. - As of September 30, 2025, the number of shareholders increased by 4.10% to 28,900, while the average circulating shares per person decreased by 3.94% to 19,913 shares [2].

Group 1 - The core viewpoint of the news is that Chutian Technology experienced a significant increase in stock price and trading volume, indicating strong investor interest and activity in the market [1] - On January 9, Chutian Technology's stock rose by 5.81%, with a trading volume of 592 million yuan, and a net financing purchase of 20.49 million yuan [1] - As of January 9, the total margin balance for Chutian Technology reached 342 million yuan, accounting for 4.25% of its market capitalization, which is above the 90th percentile of the past year [1] Group 2 - Chutian Technology, established on November 8, 2002, and listed on January 21, 2014, specializes in pharmaceutical equipment and comprehensive technical solutions [2] - The company's revenue composition includes: detection packaging solutions (24.88%), parts and after-sales service (16.44%), biological engineering solutions (14.84%), and other segments [2] - For the period from January to September 2025, Chutian Technology reported a revenue of 3.896 billion yuan, a year-on-year decrease of 6.60%, while net profit attributable to shareholders increased by 145.11% to 84.4635 million yuan [2] Group 3 - Chutian Technology has distributed a total of 361 million yuan in dividends since its A-share listing, with 117 million yuan distributed over the past three years [3] - As of September 30, 2025, the number of shareholders increased by 4.10% to 28,900, while the average circulating shares per person decreased by 3.94% to 19,913 shares [2][3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 9.3865 million shares, a decrease of 800,600 shares from the previous period, while a new shareholder, Anxin Medical Health Stock A, holds 1.7338 million shares [3]

Group 1 - The core viewpoint of the news is that Chutian Technology's stock has seen a significant increase of 5.57%, reaching a price of 10.99 yuan per share, with a trading volume of 330 million yuan and a turnover rate of 4.40%, resulting in a total market capitalization of 7.859 billion yuan [1] - Chutian Technology Co., Ltd. is located in Ningxiang City, Hunan Province, and was established on November 8, 2002, with its listing date on January 21, 2014. The company specializes in pharmaceutical equipment and overall technical solutions [1] - The main business revenue composition includes: testing and packaging solutions at 24.88%, parts and after-sales service at 16.44%, biological engineering solutions at 14.84%, sterile preparation solutions at 14.61%, pharmaceutical water equipment and engineering system integration at 13.81%, solid preparation solutions at 10.85%, EPC engineering design services at 3.57%, other products at 0.73%, and others (supplementary) at 0.28% [1] Group 2 - From the perspective of Chutian Technology's top ten circulating shareholders, a fund under Anxin Fund ranks among the top shareholders. Anxin Medical Health Stock A (010709) entered the top ten circulating shareholders in the third quarter, holding 1.7338 million shares, accounting for 0.3% of the circulating shares [2] - Anxin Medical Health Stock A (010709) was established on January 12, 2021, with a latest scale of 413 million yuan. Year-to-date returns are 6.03%, ranking 476 out of 5488 in its category; the one-year return is 60.75%, ranking 823 out of 4192; and since inception, the return is 51.17% [2] - The fund manager of Anxin Medical Health Stock A is Chi Chenshen, who has a cumulative tenure of 4 years and 362 days, with the current total asset scale of 1.545 billion yuan. The best fund return during his tenure is 42.56%, while the worst is 39.08% [2]

Group 1 - The core viewpoint of the news is that Chutian Technology's stock has seen a significant increase of 5.11%, reaching a price of 10.29 yuan per share, with a trading volume of 322 million yuan and a turnover rate of 4.54%, resulting in a total market capitalization of 7.358 billion yuan [1] - Chutian Technology Co., Ltd. is located in Ningxiang, Changsha, Hunan Province, and was established on November 8, 2002, with its listing date on January 21, 2014. The company's main business involves pharmaceutical equipment and overall technical solutions [1] - The revenue composition of Chutian Technology includes: testing and packaging solutions at 24.88%, parts and after-sales service at 16.44%, biological engineering solutions at 14.84%, sterile preparation solutions at 14.61%, pharmaceutical water equipment and engineering system integration at 13.81%, solid preparation solutions at 10.85%, EPC engineering design services at 3.57%, other products at 0.73%, and others (supplementary) at 0.28% [1] Group 2 - Anxin Fund has a presence among the top ten circulating shareholders of Chutian Technology, with Anxin Medical Health Stock A (010709) newly entering the list in the third quarter, holding 1.7338 million shares, which accounts for 0.3% of the circulating shares [2] - The estimated floating profit for Anxin Medical Health Stock A today is approximately 866,900 yuan, with the fund having a total scale of 413 million yuan and a year-to-date return of 49.3%, ranking 661 out of 4189 in its category [2] - The fund manager of Anxin Medical Health Stock A is Chi Chenshen, who has a cumulative tenure of 4 years and 360 days, with the fund's total asset scale at 1.545 billion yuan and a best return of 42.56% during his tenure [3]

Group 1 - The core viewpoint of the news is that Chutian Technology's stock has shown significant growth this year, with a 46.65% increase year-to-date and a recent rise of 12.15% over the last five trading days [1] - As of December 25, the stock price reached 10.06 yuan per share, with a market capitalization of 7.159 billion yuan and a trading volume of 1.02 billion yuan [1] - The company has seen a net inflow of main funds amounting to 1.2181 million yuan, with significant buying and selling activity from large orders [1] Group 2 - Chutian Technology, established on November 8, 2002, and listed on January 21, 2014, specializes in pharmaceutical equipment and comprehensive technical solutions [2] - The revenue composition includes: detection packaging solutions (24.88%), parts and after-sales service (16.44%), biological engineering solutions (14.84%), and other segments [2] - For the period from January to September 2025, the company reported a revenue of 3.896 billion yuan, a year-on-year decrease of 6.60%, while net profit attributable to shareholders increased by 145.11% to 84.4635 million yuan [2] Group 3 - Chutian Technology has distributed a total of 361 million yuan in dividends since its A-share listing, with 117 million yuan distributed in the last three years [3] - As of September 30, 2025, the number of shareholders increased by 4.10% to 28,900, while the average circulating shares per person decreased by 3.94% [2][3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the third largest, holding 9.3865 million shares, while a new shareholder, Anxin Medical Health Stock A, has entered the list [3]

Core Insights - On November 20, Chutian Technology experienced a decline of 1.44% with a trading volume of 209 million yuan [1] - The company reported a financing buy-in of 9.3967 million yuan and a financing repayment of 14.8762 million yuan, resulting in a net financing outflow of 5.4795 million yuan on the same day [1] - As of November 20, the total margin balance for Chutian Technology was 240 million yuan, with a financing balance of 239 million yuan, accounting for 4.01% of the circulating market value, indicating a high level compared to the past year [1] Financing and Margin Data - On November 20, Chutian Technology had a financing buy-in of 9.3967 million yuan, with a current financing balance of 239 million yuan, which is above the 90th percentile of the past year [1] - The company had no shares repaid or sold in the margin trading on the same day, with a margin balance of 431,500 yuan and a margin volume of 44,900 shares, also above the 80th percentile of the past year [1] Company Overview - Chutian Technology, established on November 8, 2002, and listed on January 21, 2014, is based in Ningxiang, Hunan Province, and specializes in pharmaceutical equipment and comprehensive technical solutions [2] - The company's revenue composition includes: detection packaging solutions (24.88%), parts and after-sales services (16.44%), biological engineering solutions (14.84%), sterile preparation solutions (14.61%), pharmaceutical water equipment (13.81%), solid preparation solutions (10.85%), EPC engineering design services (3.57%), and other products (1.01%) [2] - As of September 30, the number of shareholders increased by 4.10% to 28,900, with an average of 19,913 circulating shares per person, a decrease of 3.94% [2] Financial Performance - For the period from January to September 2025, Chutian Technology reported a revenue of 3.896 billion yuan, a year-on-year decrease of 6.60%, while the net profit attributable to shareholders increased by 145.11% to 84.4635 million yuan [2] Dividend and Shareholding - Chutian Technology has distributed a total of 361 million yuan in dividends since its A-share listing, with 117 million yuan distributed over the past three years [3] - As of September 30, 2025, the third-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 9.3865 million shares, a decrease of 800,600 shares from the previous period [3] - Anxin Medical Health Stock A is a new entrant among the top ten circulating shareholders, holding 1.7338 million shares [3]

Group 1 - The core viewpoint of the news is that Chutian Technology's stock has seen a significant increase of 6.07%, reaching a price of 11.88 CNY per share, with a trading volume of 381 million CNY and a turnover rate of 5.75%, resulting in a total market capitalization of 7.013 billion CNY [1] - Chutian Technology Co., Ltd. is located in Changsha, Hunan Province, and was established on November 8, 2002, with its listing date on January 21, 2014. The company's main business involves pharmaceutical equipment and comprehensive technical solutions [1] - The revenue composition of Chutian Technology includes: testing and packaging solutions (24.88%), parts and after-sales service (16.44%), bioengineering solutions (14.84%), sterile preparation solutions (14.61%), pharmaceutical water equipment and engineering system integration (13.81%), solid preparation solutions (10.85%), EPC engineering design services (3.57%), other products (0.73%), and others (0.28%) [1] Group 2 - Anxin Fund has a fund that ranks among the top ten circulating shareholders of Chutian Technology. The Anxin Medical Health Stock A (010709) fund entered the top ten circulating shareholders in the third quarter, holding 1.7338 million shares, which accounts for 0.3% of the circulating shares. The estimated floating profit today is approximately 1.179 million CNY [2] - The Anxin Medical Health Stock A (010709) fund was established on January 12, 2021, with a latest scale of 413 million CNY. Year-to-date returns are 62.45%, ranking 245 out of 4216 in its category; the one-year return is 52.89%, ranking 478 out of 3894; and since inception, the return is 55.12% [2]

Core Insights - On October 22, Chutian Technology experienced a decline of 2.53% with a trading volume of 177 million yuan, indicating a negative market sentiment towards the company [1] - The company reported a net financing outflow of 503.73 million yuan on the same day, suggesting a higher level of selling pressure compared to buying [1] - As of October 22, the total margin balance for Chutian Technology stood at 233 million yuan, which is 4.49% of its market capitalization, indicating a high level of margin activity [1] Financing and Margin Trading - On October 22, Chutian Technology had a financing buy-in amount of 15.22 million yuan, while the financing repayment was 20.26 million yuan, leading to a net financing buy of -5.04 million yuan [1] - The current financing balance of 233 million yuan exceeds the 90th percentile of the past year, indicating a high level of leverage [1] - In terms of securities lending, the company repaid 500 shares and sold 1,300 shares on October 22, with a selling amount of 11,500 yuan, reflecting active short-selling [1] Company Overview - Chutian Technology, established on November 8, 2002, and listed on January 21, 2014, is based in Ningxiang, Hunan Province, and specializes in pharmaceutical equipment and comprehensive technical solutions [2] - The company's revenue composition includes: detection packaging solutions (24.88%), accessories and after-sales services (16.44%), and various other solutions, with the total revenue for the first half of 2025 being 2.417 billion yuan, a year-on-year decrease of 14.55% [2] - The net profit attributable to shareholders for the same period was -12.30 million yuan, but this represents an 85.11% year-on-year improvement [2] Shareholder and Dividend Information - Since its A-share listing, Chutian Technology has distributed a total of 361 million yuan in dividends, with 117 million yuan distributed over the last three years [3] - As of June 30, 2025, the number of shareholders increased by 3.48% to 27,800, while the average circulating shares per person decreased by 3.35% to 20,731 shares [2][3] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 10.19 million shares, an increase of 3.45 million shares from the previous period [3]